The innovative pharmaceutical companies associated with INFARMA are keen on the fact that the clinical studies in Poland were conducted in accordance with the highest world standards regarding quality and ethics. Pharmaceutical companies care for transparency and unambiguity of provisions, since it directly translates to efficiency in conducting clinical trials.
The principles for conducting clinical trials
In October 2010, INFARMA and the Association for Good Clinical Practices in Poland adopted the document "The Principles for Conducting Clinical Trials" which is an example of industry self-regulation resulting from the desire to act in accordance with transparent rules. It defines the standards for the organization of financing and the reporting of clinical trials.
